Zhendong Pharmacy(SZ:300158) Xin Lang Zheng Quan·2025-09-16 02:46Core Viewpoint - Zhendong Pharmaceutical's stock has experienced significant fluctuations, with a year-to-date increase of 70.14%, but a recent decline in the last five and twenty trading days [1][2]. Company Overview - Zhendong Pharmaceutical, established on November 15, 1995, and listed on January 7, 2011, is located in Changzhi, Shanxi Province. The company specializes in the research, production, and sales of generic and innovative drugs across various therapeutic areas, including oncology, hair care, digestion, urology, and cardiovascular health [2]. - The company's revenue composition includes 54.82% from traditional Chinese medicine, 43.10% from chemical drugs, 1.98% from other sources, and 0.10% from sales materials [2]. Financial Performance - For the first half of 2025, Zhendong Pharmaceutical reported a revenue of 1.457 billion yuan, a year-on-year decrease of 3.30%. The net profit attributable to the parent company was 7.9313 million yuan, reflecting a significant decline of 74.13% compared to the previous year [2]. - The company has distributed a total of 3.372 billion yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 5.04% to 46,100, with an average of 21,777 circulating shares per person, an increase of 5.31% [2]. - Hong Kong Central Clearing Limited is the fourth-largest circulating shareholder, holding 7.9704 million shares, an increase of 5.0578 million shares from the previous period [3].